These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3940525)

  • 1. Reductive activation of nitroimidazoles in anaerobic microorganisms.
    Müller M
    Biochem Pharmacol; 1986 Jan; 35(1):37-41. PubMed ID: 3940525
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity.
    Goldman P; Koch RL; Yeung TC; Chrystal EJ; Beaulieu BB; McLafferty MA; Sudlow G
    Biochem Pharmacol; 1986 Jan; 35(1):43-51. PubMed ID: 3753580
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of clinically utilized 5-nitroimidazoles on microorganisms.
    Müller M
    Scand J Infect Dis Suppl; 1981; 26():31-41. PubMed ID: 6941454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent interaction of 5-nitroimidazoles with DNA and protein in vitro: mechanism of reductive activation.
    Kedderis GL; Argenbright LS; Miwa GT
    Chem Res Toxicol; 1989; 2(3):146-9. PubMed ID: 2519718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of nitroimidazole derivatives by hydrogenosomal extracts of Trichomonas vaginalis.
    Yarlett N; Gorrell TE; Marczak R; Müller M
    Mol Biochem Parasitol; 1985 Jan; 14(1):29-40. PubMed ID: 3872412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis.
    Rossignol JF; Maisonneuve H; Cho YW
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):63-72. PubMed ID: 6698665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole (flagyl) and misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo.
    Basag SH; Dunlop JR; Searle AJ; Willson RL
    Br J Cancer Suppl; 1978 Jun; 3():132-5. PubMed ID: 354677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
    Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA
    Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of nitrimidazine and metronidazole in the treatment of trichomonas infections].
    Goldman JA
    Harefuah; 1974 May; 86(9):463-5. PubMed ID: 4839423
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to the resistance of Trichomonas vaginalis to metronidazol].
    Valent M; Catár G; Jánoska A; Scholz W
    Bratisl Lek Listy; 1969 Jul; 52(1):58-61. PubMed ID: 5806835
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.
    Edwards DI
    Br J Vener Dis; 1980 Oct; 56(5):285-90. PubMed ID: 7000306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of metronidazole and tinidazole in patients with mixed aerobic--anaerobic infections.
    Mattie H; Dijkmans BA; van Gulpen C
    J Antimicrob Chemother; 1982 Aug; 10 Suppl A():59-64. PubMed ID: 7118776
    [No Abstract]   [Full Text] [Related]  

  • 13. Metronidazole and tinidazole in a single large dose for treating urogenital infections with Trichomonas vaginalis in men.
    Kawamura N
    Br J Vener Dis; 1978 Apr; 54(2):81-3. PubMed ID: 305809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes.
    Perez-Reyes E; Kalyanaraman B; Mason RP
    Mol Pharmacol; 1980 Mar; 17(2):239-44. PubMed ID: 6248760
    [No Abstract]   [Full Text] [Related]  

  • 15. Manipulation of end-product distribution in strict anaerobes.
    Rao G; Ward PJ; Mutharasan R
    Ann N Y Acad Sci; 1987; 506():76-83. PubMed ID: 3481233
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase.
    Clarke ED; Goulding KH; Wardman P
    Biochem Pharmacol; 1982 Oct; 31(20):3237-42. PubMed ID: 6897358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New data on the mechanism and speed of action of nitroimidazoles on prokaryota and eukaryota with and without mitochondria.
    Carneri I; Bianchi A; Castellino S; Meinardi G; Trane F
    Arzneimittelforschung; 1976; 26(5):765-9. PubMed ID: 1085631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug resistance of trichomonas vaginalis].
    Slucki L
    Wiad Lek; 1968 Apr; 21(7):541-4. PubMed ID: 5669991
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of hydrogen production in drug-resistant and susceptible Trichomonas vaginalis strains by a range of nitroimidazole derivatives.
    Lloyd D; Yarlett N; Yarlett NC
    Biochem Pharmacol; 1986 Jan; 35(1):61-4. PubMed ID: 3000386
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental models for the evaluation of systemic trichomonacides. Models for evaluation of trichomonacides.
    Tsai YH; Price KE
    Chemotherapy; 1973; 18(6):348-57. PubMed ID: 4542601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.